Discover how Regenerative Medicine is studied as a potential option for those seeking to manage their symptoms.
Whether you have recently been diagnosed or battling this condition for years, this breakthrough in Regenerative Medicine may be a potential opportunity for an alternative option in your journey to wellness.
Studies have shown the following potential symptom improvements:
Discover our wide range of treatments by calling us at (800) 531-0831
Multiple Sclerosis (MS) is a degenerative condition in which the central nervous system (CNS) is attacked by an individual’s own immune system. In specific, the protective tissue called the myelin sheath which surrounds nerve fibers in the brain is attacked by an abnormal immune response. This results in inflammation and exposure of nerve fibers, which leads to a disoriented signal flow between nerve cells and the brain. The disruption of communication between the brain and the body leads to a broad range of symptoms, including loss of motor skills, coordination, spasticity, and cognitive abilities.
Multiple Sclerosis can be challenging to manage, as the progression and severity of symptoms affect each patient differently. For example, some patients may experience abnormal sensations in the extremities, decreased tactility in the hands, fatigue, loss of balance, and muscle aches. Individuals with the most severe symptoms may experience bladder problems, difficulty walking, dizziness, muscle spasticity, and loss of vision. Symptoms may appear in episodic periods of worsening, known as flare-ups, and can cause progressive deterioration of neurological functions.
Traditionally, the primary method of treatment for Multiple Sclerosis has focused on preventing the abnormal response of the immune system. This employs the use of medications to delay the abnormal immune response. Recently, however, an alternate treatment method has been introduced.
Multiple Sclerosis (MS) is a chronic autoimmune disease that affects the central nervous system, causing a wide range of debilitating symptoms. Traditional treatment options for MS primarily focus on managing symptoms and slowing down the progression of the disease. However, recent advancements in medical research have unveiled a potential breakthrough: stem cell therapy. Stem cell treatment for multiple sclerosis offers a promising avenue for individuals, aiming to not only manage symptoms but potentially repair damaged nerve cells and improve the overall quality of life.
Regenerative medicine for multiple sclerosis aims to repair the damage caused to the myelin sheath—the protective covering of nerve fibers—by targeting the underlying immune dysfunction. By using stem cells, researchers hope to restore lost function and provide relief from symptoms. The procedure involves either transplanting the patient’s own stem cells (autologous transplantation) or utilizing stem cells from a donor (allogeneic transplantation).
Research has shown stem cells can repair myelin sheaths. This protective coating surrounds nerve fibers of the central nervous system that are damaged by multiple sclerosis (MS). Additionally, stem cells are capable of modulating the immune response which may be involved in MS development.
Regenerative Medicine is the latest treatment option for Multiple Sclerosis. It may reduce inflammation and slow down or stop the progression of the disease.
Regenerative Medicine is an option to potentially manage the symptoms of this condition. Researchers have made great strides by using Regenerative Medicine therapy in their studies for such conditions.
In particular, Regenerative Medicine may encompass the use of regenerative biological products, which have the potential to regenerate lost or damaged cells, including myelin sheath tissue which becomes damaged in Multiple Sclerosis. Moreover, regenerative medicine can also modulate the immune system to temporarily disable the abnormal attack on healthy cells.
Regenerative Medicine is still considered an experimental procedure and not approved by the FDA. Patients must consider realistic expectations in their research and possible therapy options. To learn more about regenerative medicine for ms, call us today!
Discover our wide range of treatments by calling us at (800) 531-0831
Speak with a Care Coordinator today for a more accurate assessment of your condition and therapy options.
Stemedix speaks with Thomas R. and his wife about their experience with Stemedix and his regenerative medicine therapy for Multiple Sclerosis. Thomas has Relapsing Remitting Multiple Sclerosis (RRMS).
Our Board-Certified Physicians specialize in regenerative medicine. They stay abreast of the latest developments in regenerative medicine research. Each patient is screened and reviewed before being approved for therapy.
Each patient is thoroughly reviewed to ensure their safety for treatment. The physicians will then determine potential benefit candidacy. If approved, a customized treatment plan is offered for the patient.
Stemedix can help coordinate patients with necessary wheelchair transportation, medical equipment, and Care Giving services as needed during their stay. Your Care Coordinator is available for questions and assistance.
A peer-reviewed review of mesenchymal stromal cell signaling, remyelination research in multiple sclerosis, and neural protection studies in Parkinson’s disease.
Multiple sclerosis (MS) is a condition that affects the central nervous system, disrupting the ways in which information flows within and to and from the brain. Its cause is unknown, though experts believe it may result from a combination of genetic and environmental factors. The trajectory and symptoms of the disease are often unpredictable. People…
The most common form of multiple sclerosis is a relapsing-remitting MS. In relapsing-remitting multiple sclerosis, patients have relatively quiet, healthy times interrupted by disease flares. MS flares can cause many different neurological symptoms. The disease can interfere with any number of bodily processes, from walking to seeing, to urinating. For many years, the only treatments…